These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30619858)

  • 1. Oligosaccharide Chromatographic Techniques for Quantitation of Structural Process-Related Impurities in Heparin Resulting From 2-O Desulfation.
    Anger P; Martinez C; Mourier P; Viskov C
    Front Med (Lausanne); 2018; 5():346. PubMed ID: 30619858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of anti-factor Xa active, 3-O-sulfated glucosamine-rich sequences by controlled desulfation of oversulfated heparins.
    Naggi A; De Cristofano B; Bisio A; Torri G; Casu B
    Carbohydr Res; 2001 Dec; 336(4):283-90. PubMed ID: 11728396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of N-sulphated disaccharide units in heparin-like polysaccharides.
    Jacobsson I; Höök M; Pettersson I; Lindahl U; Larm O; Wirén E; von Figura K
    Biochem J; 1979 Apr; 179(1):77-87. PubMed ID: 157737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in heparin structural analysis by chromatography technologies].
    Ouyang Y; Yi L; Qiu L; Zhang Z
    Se Pu; 2023 Feb; 41(2):107-121. PubMed ID: 36725707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical Approaches to Prepare Modified Heparin and Heparosan Polymers for Biological Studies.
    Raman K; Arungundram S
    Methods Mol Biol; 2022; 2303():289-296. PubMed ID: 34626387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of antithrombin-protease interactions by semisynthetic low-molecular-weight heparins with different sulfation patterns.
    Sissi C; Naggi A; Torri G; Palumbo M
    Semin Thromb Hemost; 2003 Dec; 29(6):661-70. PubMed ID: 14719183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin sodium compliance to USP monograph: structural elucidation of an atypical 2.18 ppm NMR signal.
    Mourier PA; Guichard OY; Herman F; Viskov C
    J Pharm Biomed Anal; 2012; 67-68():169-74. PubMed ID: 22579602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligosaccharide mapping of heparinase I-treated heparins by hydrophilic interaction liquid chromatography separation and online fluorescence detection and electrospray ionization-mass spectrometry characterization.
    Galeotti F; Volpi N
    J Chromatogr A; 2016 May; 1445():68-79. PubMed ID: 27062721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards the assembly of heparin and heparan sulfate oligosaccharide libraries: efficient synthesis of uronic acid and disaccharide building blocks.
    Saito A; Wakao M; Deguchi H; Mawatari A; Sobel M; Suda Y
    Tetrahedron; 2010 May; 66(22):3951-3962. PubMed ID: 20473366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparinase Digestion of 3-
    Mourier P
    Front Med (Lausanne); 2022; 9():841726. PubMed ID: 35433769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and structural characterization of large heparin-derived oligosaccharides.
    Pervin A; Gallo C; Jandik KA; Han XJ; Linhardt RJ
    Glycobiology; 1995 Feb; 5(1):83-95. PubMed ID: 7772871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide.
    Naggi A; Torri G; Casu B; Oreste P; Zoppetti G; Li JP; Lindahl U
    Semin Thromb Hemost; 2001 Oct; 27(5):437-43. PubMed ID: 11668413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Identification and Quantitation of Basic Building Blocks for Low-Molecular Weight Heparin.
    Sun X; Sheng A; Liu X; Shi F; Jin L; Xie S; Zhang F; Linhardt RJ; Chi L
    Anal Chem; 2016 Aug; 88(15):7738-44. PubMed ID: 27388010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrolytic Degradation of Heparin in Acidic Environments: Nuclear Magnetic Resonance Reveals Details of Selective Desulfation.
    Kozlowski AM; Yates EA; Roubroeks JP; Tømmeraas K; Smith AM; Morris GA
    ACS Appl Mater Interfaces; 2021 Feb; 13(4):5551-5563. PubMed ID: 33471995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of unfractionated heparins studied in connection with species, source, and production processes.
    Bianchini P; Liverani L; Mascellani G; Parma B
    Semin Thromb Hemost; 1997; 23(1):3-10. PubMed ID: 9156404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Far-ultraviolet circular dichroism and uronic acid components of anticoagulant deca-, dodeca-, tetradeca-, and octadecasaccharide heparin fractions.
    Stone AL
    Arch Biochem Biophys; 1985 Jan; 236(1):342-53. PubMed ID: 3966799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin.
    Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugiura M; Sugahara K
    Biochemistry; 1999 Jan; 38(2):838-47. PubMed ID: 9888825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin sodium compliance to the new proposed USP monograph: elucidation of a minor structural modification responsible for a process dependent 2.10 ppm NMR signal.
    Mourier PA; Guichard OY; Herman F; Viskov C
    J Pharm Biomed Anal; 2011 Jan; 54(2):337-44. PubMed ID: 20934294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural studies on heparin. Tetrasaccharides obtained by heparinase degradation.
    Linker A; Hovingh P
    Carbohydr Res; 1984 Apr; 127(1):75-94. PubMed ID: 6713443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.